Complementing our high-potency Vitamin K2 MK7 supply, we manufacture standardized botanical extracts, liposomal vitamins, and functional carriers engineered for co-formulation in bone density, metabolic balance, and dietary formulations.
Vitamin K2, generically known as menaquinone, encompasses a family of fat-soluble vitamers differing in the length and saturation of their multiprenyl side chains at the 3-position of the 2-methyl-1,4-naphthoquinone nucleus. Among these vitamers, Menaquinone-7 (MK-7) represents the gold standard for clinical bioavailability, systemic tissue distribution, and therapeutic plasma half-life. While short-chain menaquinones like MK-4 exhibit a transient serum clearance rate of approximately 1.5 to 2 hours, naturally fermented MK-7 exhibits a prolonged circulatory retention exceeding 72 hours. This persistent systemic presence allows uniform carboxylation of extra-hepatic vitamin K-dependent proteins (VKDPs), most critically Osteocalcin (bone Gla protein) in osteoblasts and Matrix Gla Protein (MGP) in vascular smooth muscle cells.
From an analytical perspective, pharmaceutical performance hinges entirely on stereoisomeric purity. Vitamin K2 MK7 occurs in two geometric configurations: the biologically active all-trans isomer and inactive cis isomers. Inactive cis-conformers fail to dock effectively into the active site of the enzyme gamma-glutamyl carboxylase (GGCX) in human endoplasmic reticulum membranes. BKYULA Biotech utilizes advanced non-solvent, non-chemical deep-tank biofermentation of Bacillus subtilis var. natto, followed by multi-stage crystallization to consistently achieve an all-trans MK-7 isomeric profile of >99.0% as quantified by high-performance liquid chromatography (HPLC) equipped with photodiode array (PDA) detection in compliance with the United States Pharmacopeia (USP) and European Pharmacopoeia (Ph. Eur.) monographs.
MK-7 is incorporated into low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL), facilitating targeted receptor-mediated delivery to vascular endothelia, arterial walls, and trabecular bone matrices.
Serves as the indispensable obligate cofactor for gamma-carboxylation of 5 glutamate residues on MGP. Uncarboxylated MGP (dp-ucMGP) is the primary pathological biomarker for medial vascular calcification and coronary stiffness.
In synergistic matrix formulation alongside Vitamin D3 (Cholecalciferol), MK-7 channels circulating ionized serum calcium directly into hydroxyapatite bone crystal scaffolds, preventing arterial deposition.
Formulating Vitamin K2 MK7 within multivitamin and mineral matrices presents profound stability obstacles. Unprotected menaquinone molecules degrade rapidly when exposed to alkaline mineral salts, notably calcium carbonate, tribasic calcium phosphate, magnesium oxide, and trace transition minerals (copper, iron, zinc). Under normal ambient shelf storage, unprotected MK-7 in direct contact with magnesium oxide can experience over 85% active degradation within three months.
To resolve this formulation challenge for dietary supplement contract manufacturers serving Bender and adjacent Eastern European territories, BKYULA Biotech engineered our proprietary Dual-Layer Cross-Linked Microencapsulation Technology. By enveloping crystalline all-trans MK-7 within an impermeable hydrocolloid matrix composed of modified starches, antioxidant ascorbates, and protective edible shell structures, our stabilized beadlet grades resist alkaline degradation, pressure-induced tableting friction, and elevated humidity, ensuring full shelf-life label claim compliance over a 36-month validation cycle.
We supply diverse delivery forms specifically formulated for softgel encapsulation, direct tablet compression, two-piece hard capsules, functional liquid dispersions, and veterinary premixes.
| Product Grade Code | Standard Concentration | Physical Carrier Matrix | All-Trans Isomeric Purity | Target Application in Formulation |
|---|---|---|---|---|
| BKY-K2-OIL (Fermented) | 1,500 ppm to 10,000 ppm | MCT Oil / Refined Sunflower Oil | > 99.2% (HPLC) | Liquid dropper bottles, lipid-based softgel capsules |
| BKY-K2-PWD (Water-Dispersible) | 1,000 ppm to 5,000 ppm (0.1%-0.5%) | Maltodextrin / Gum Acacia | > 99.0% (HPLC) | Effervescent tablets, functional powdered drinks, infant food |
| BKY-K2-BEAD (Protected) | 2,000 ppm to 10,000 ppm (0.2%-1.0%) | Microencapsulated Beadlets (Starch) | > 99.5% (HPLC) | Direct compression with high-dose Calcium & Magnesium |
| BKY-K2-PURE (API / Active) | 98.0% - 99.5% Crystalline | Neat Active Substance | > 99.8% (HPLC) | Pharmaceutical preparation, custom dilution, lab reference |
| BKY-K2-FEED (Feed-Premix) | 1,000 ppm to 2,000 ppm | Rice Hull Powder / Silica Carrier | > 98.5% (HPLC) | FAMI-QS compliant veterinary nutrition, poultry bone health |
Bender occupies an advantageous strategic position along the Dniester River logistics axis, connecting southeastern Moldovan industrial manufacturing with regional European transit corridors. Localized industrial consumers utilize BKYULA Biotech Vitamin K2 MK7 across three core manufacturing sectors.
Private-label dietary supplement producers situated in and around Bender are increasingly formulating targeted longevity formulas. With local aging demographics experiencing heightened demand for cardiovascular and osteoporotic maintenance, our stabilized microencapsulated K2 MK7 allows local toll-manufacturers to blend stable, high-potency Calcium + D3 + K2 tablets and hard capsules without premature chemical degradation.
The agro-processing cluster surrounding the Dniester basin supports dynamic dairy and lipid processing. Formulators leverage our oil-soluble Vitamin K2 MK7 (MCT or sunflower carrier) to fortify premium drinking milks, fortified spreads, infant nutrition, and cardiovascular cooking oils, delivering verified heat stability during pasteurization and clean-label non-GMO plant origin.
Industrial egg-laying operations and broilers face high risks of skeletal defects and cage fatigue. Under our FAMI-QS quality management protocols, feed-grade Vitamin K2 MK7 is incorporated into mineral-rich poultry and breeder premixes in Bender, enhancing shell calcification elasticity, accelerating calcium uptake, and substantially reducing sub-clinical breakage rates.
B2B buyers and contract developers operating in Bender operate within a unique geographical nexus requiring absolute paperwork veracity, stable documentation, and strict conformance with Moldovan National Agency for Food Safety (ANSA) standards, as well as harmonized European Pharmacopoeia benchmarks. Sourcing raw materials from non-verified traders frequently results in delayed customs processing, batch rejections, or active potency loss during transit.
BKYULA Biotech removes this vulnerability by managing comprehensive batch traceability from fermentation tank to your destination warehouse. Each export container delivered to Bender is accompanied by verified Certificates of Analysis (COA) specifying exact HPLC all-trans retention times, validated low heavy metal burdens (Pb < 0.5 ppm, As < 0.2 ppm, Cd < 0.1 ppm, Hg < 0.05 ppm), total plate counts, absence of pathogenic microbes (Salmonella, E. coli, Listeria), and residual solvent gas chromatography profiles complying with ICH Q3C guidelines.
Analysis of emerging regulatory frameworks, consumer habits, and pharmaceutical contract manufacturing across Eastern Europe points to three pivotal industry developments.
Historical reliance on synthetic Vitamin K2 MK-4 is diminishing. Brands formulated in Bender recognize that MK-4 requires milligram-level dosing (45 mg/day) with frequent boluses, whereas naturally fermented MK-7 achieves comprehensive systemic carboxylating efficacy at microgram-level dosing (75–180 mcg/day), significantly lowering cost-per-dose and enabling compact single-tablet daily compliance.
As regional commercial operators align product dossiers with broader European Union regulations and export requirements, demand for documented non-animal, soy-free or chickpea-fermented Vitamin K2 is accelerating. Importers in Bender demand verified non-novel processing parameters, non-GMO certificates, and validated allergen-free profiles that streamline national and international health product notifications.
Monotherapy supplement formulations are being rapidly phased out in favor of comprehensive synergistic complexes. Manufacturers in Bender are actively blending Vitamin K2 MK-7 with Liposomal Vitamin D3, Marine Collagen Peptides, Sulforaphane-rich botanical extracts, and bioactive mineral chelates (e.g., Magnesium Bisglycinate). This shifts manufacturing priority toward microencapsulated, non-reactive raw materials.
Backed by nearly 15 years of dedicated botanical extraction and biofermentation manufacturing expertise, BKYULA Biotech Co., Ltd. provides global procurement teams with verifiable quality, audit transparency, and flexible technical support.
Our manufacturing workshops, raw material storage, and quality control infrastructure have been audited and verified onsite by the SGS Group. Buyers in Bender gain direct access to independent assessment audits verifying factory authenticity and operational safety.
Our quality management protocols strictly enforce ISO 9001:2015, ISO 22000, HACCP, HALAL, KOSHER, and FAMI-QS standards. For organic portfolios, selected ingredients carry USDA Organic, EU Organic, and EOS conformity.
Equipped with twin Agilent HPLC Systems, UV-Vis Spectrophotometers, analytical precision balances, and class-10,000 clean microbiologic incubators, every batch undergoes mandatory pre-shipment testing for isomer fraction, assay, heavy metals, and residual solvents.
To facilitate R&D trials, pilot batches, and commercial scale-up for contract manufacturers in Bender, our standard minimum order quantity starts from just 1 kg for standard powders, and down to 1 gram for pure API-grade actives.
We accommodate global trade delivery terms including FOB, CIF, CIP, FCA, and fully cleared DDP door-to-door courier freight into Eastern Europe. Packaged under inert nitrogen purging in multi-layer aluminum vacuum barrier drums to eliminate moisture ingress.
Beyond active ingredient export, our technical team assists your R&D scientists with customized powder blending, specialized granulation for high-speed rotary presses, enteric coating, and tailored pre-mix compounding.
Clear, definitive answers to technical, regulatory, shipping, and analytical inquiries frequently raised by purchasing directors and QA teams serving Bender and regional manufacturing facilities.
Consult with our biochemical application engineers to identify the ideal Vitamin K2 MK7 grade for your tablet, capsule, or fortified food application in Bender. Rapid quotation and technical documentation provided within 24 hours.